ArticlePharmaceutical research2004
D-glucose triggers multidrug resistance-associated protein (MRP)-mediated secretion of fluorescein across rat jejunum in vitro.
Article in Pharmaceutical research, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 21 citations in OpenAlex.
- Adenosine receptor agonist NECA increases cerebral extravasation of fluorescein and low molecular weight dextran independent of blood-brain barrier modulation.Scientific reports · 2016Article
- Hindlimb heating increases vascular access of large molecules to murine tibial growth plates measured by in vivo multiphoton imaging.Journal of applied physiology (Bethesda, Md. : 1985) · 2014Article
- Decreased blood-brain barrier permeability to fluorescein in streptozotocin-treated rats.Neuroscience letters · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo examine the transport characteristics of the multidrug resistance-associated protein (MRP) substrate fluorescein across the isolated rat small intestinal segments.
methodsThe transport of fluorescein was studied in side-by-side diffusion chambers under short-circuited conditions at physiological pH.
resultsThe serosal-to-mucosal permeability of fluorescein significantly exceeded the permeability in the opposite direction in the jejunum, but not in the ileum. This asymmetry in transport in the jejunum was observed only when D-glucose was present at the mucosal side of the tissue, and not in the presence of D-galactose or D-mannitol. In the presence of D-glucose at the mucosal side, serosal-to-mucosal permeability of fluorescein in the jejunum can be divided into an active (Michaelis-Menten constant, KM = 1.07 mM; maximum flux of the substrate. Jmax = 14.0 nmol/h x cm2) and a passive component (passive permeability, Ppas = 2.51 x 10(-6) cm/s). The polarization of fluorescein transport was almost completely abolished by MRP inhibitor, benzbromarone (50 or 100 microM, applied apically), and by MRP/P-glycoprotein inhibitor, verapamil (200 microM, applied apically).
conclusionsD-glucose at the mucosal side activates fluorescein secretion across rat jejunum by an apical MRP, most probably by isoform 2 (MRP2), which could have an impact on the intestinal absorption of MRP substrates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.